
GPCR19
GPCR19, também conhecido como GPR19, é um membro da família dos receptores acoplados à proteína G, com funções que ainda estão sendo elucidadas em vários processos fisiológicos. Embora menos caracterizado do que outros GPCRs, o GPCR19 é de interesse em pesquisas focadas na descoberta de novos alvos terapêuticos para doenças metabólicas, câncer e distúrbios neurológicos. Na CymitQuimica, oferecemos uma seleção de ferramentas de pesquisa e reagentes para apoiar suas investigações sobre as funções e potenciais aplicações terapêuticas do GPCR19.
Foram encontrados 31 produtos de "GPCR19"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Hyodeoxycholic acid
CAS:<p>Hyodeoxycholic acid (NSC 60672) has been used in trials studying the treatment of Hypercholesterolemia.</p>Fórmula:C24H40O4Pureza:97.29% - 98.82%Cor e Forma:SolidPeso molecular:392.57Deoxycholic acid
CAS:<p>Deoxycholic acid (Cholanoic Acid) is a bile acid formed by bacterial action from cholate.</p>Fórmula:C24H40O4Pureza:99.91% - 99.91%Cor e Forma:Crystals From Alc SolidPeso molecular:392.57Ursodeoxycholic acid
CAS:<p>Ursodeoxycholic acid (UDCA) is a potent inhibitor of liver-specific fatty acid transporter 5 (FATP5),inhibits cholesterol absorption. High-Quality, Low-Cost!</p>Fórmula:C24H40O4Pureza:99.74% - ≥95%Cor e Forma:White - Almost White Solid PowderPeso molecular:392.57PEN (rat)
CAS:<p>PEN (rat) is an Endogenous peptide GPR83 agonist. ProSAAS-derived neuropeptide.</p>Fórmula:C102H169N27O33Pureza:98%Cor e Forma:SolidPeso molecular:2301.62TGR5 agonist 1
<p>Compound 18 (TGR5 agonist 1) is a potent agonist of TGR5, exhibiting an EC50 value of 0.31 µM [1].</p>Fórmula:C28H48NNaO6SCor e Forma:SolidPeso molecular:549.74TGR5 agonist 4
<p>TGR5 agonist 4 (compound 19), a derivative of cholic acid, selectively activates the TGR5 receptor with an effective concentration (EC50) of 4 μM [1].</p>Fórmula:C24H38F2O5Cor e Forma:SolidPeso molecular:444.555-HT7R antagonist 1 free base
CAS:<p>5-HT7R antagonist 1 (free base) is a G protein-biased antagonist for the 5-HT 7 R receptor, with a dissociation constant (K i) of 6.5 nM.</p>Fórmula:C14H17ClN4Cor e Forma:SolidPeso molecular:276.77PEN (human)
CAS:<p>PEN (human) is an Endogenous peptide GPR83 agonist. ProSAAS-derived neuropeptide.</p>Fórmula:C97H159N27O32Pureza:98%Cor e Forma:SolidPeso molecular:2215.49Cholic Acid 7-sulfate
CAS:<p>Cholic acid 7-sulfate: a cholic acid metabolite with added sulfate at position 7, increased in feces of male mice with specific diets.</p>Fórmula:C24H40O8SCor e Forma:SolidPeso molecular:488.64TGR5 agonist 2
<p>TGR5 agonist 2 (compound 19) serves as a highly potent agonist of TGR5, demonstrating an EC50 value of 0.27 µM [1].</p>Fórmula:C29H50NNaO6SCor e Forma:SolidPeso molecular:563.77TGR5 agonist 6
CAS:<p>Compound 22b, also known as TGR5 agonist 6, is a non-systemic, intestine-targeted TGR5 agonist that demonstrates significant and sustained blood glucose-lowering effects with an acceptable safety profile.</p>Fórmula:C42H48Cl2N6O6Cor e Forma:SolidPeso molecular:803.77TGR5 agonist 7
<p>TGR5 agonist 7 (Compound 22-Na) is an intestine-restricted, orally active agonist of the G protein-coupled bile acid receptor TGR5 (GPBAR1 or GPR131) with an EC50 of less than 1 μM. In mouse models, it demonstrates blood glucose-lowering effects, making it useful for diabetes research.</p>Fórmula:C37H59N2NaO9SCor e Forma:SolidPeso molecular:730.93Triamterene
CAS:<p>Triamterene is a barosensitive epithelial sodium channel (ENaC) blocker with a diuretic effect. It can also act as an inhibitor of the TGR5 receptor, reducing GLP-1 secretion and cAMP level increases induced by TGR5 activation in a dose-dependent manner.</p>Fórmula:C12H11N7Pureza:99.77%Cor e Forma:Yellow Yellow SolidPeso molecular:253.26BAR502
CAS:<p>BAR502 is a dual GPBAR1 and FXR agonist (IC50s: 0.4 μM and 2 μM).</p>Fórmula:C25H44O3Pureza:99.95%Cor e Forma:SolidPeso molecular:392.62BAR501
CAS:<p>BAR501是高效选择性的 GPBAR1激动剂(EC50:1 μM)。</p>Fórmula:C26H46O3Pureza:99.29% - 99.68%Cor e Forma:SolidPeso molecular:406.64TC-G 1005
CAS:<p>TC-G 1005 is a potent and selective GPBA agonist (EC50 :0.72 nM; hTGR5).</p>Fórmula:C25H25N3O2Pureza:98.60% - 99.78%Cor e Forma:SolidPeso molecular:399.48Deoxycholic acid sodium salt
CAS:<p>Deoxycholic acid sodium salt (Sodium deoxycholate) can activate the G protein-coupled bile acid receptor TGR5 that stimulates BAT thermogenic activity.</p>Fórmula:C24H39NaO4Pureza:97.88% - 99.75%Cor e Forma:Cream Crystalline PowderPeso molecular:414.56SBI-115
CAS:<p>SBI-115 is an antagonist of TGR5. SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5</p>Fórmula:C14H13ClN2O4SPureza:99.53% - 99.78%Cor e Forma:SolidPeso molecular:340.78TGR5 Receptor Agonist
CAS:<p>TGR5 is a potent TGR5(GPCR19) agonist.</p>Fórmula:C18H14Cl2N2O2Pureza:99.77% - ≥95%Cor e Forma:SolidPeso molecular:361.22PEN (human) aceate
<p>PEN (human) aceate, one of the most abundant hypothalamic neuropeptide and derived from the proprotein ProSAAS, is an endogenous ligand of GPR83.</p>Fórmula:C99H163N27O34Pureza:99.25%Cor e Forma:SolidPeso molecular:2275.51SB756050
CAS:<p>SB756050 is a specific TGR5 agonist.</p>Fórmula:C21H28N2O8S2Pureza:98.78% - >99.99%Cor e Forma:SolidPeso molecular:500.59Ursodeoxycholic acid sodium
CAS:<p>Ursodeoxycholic acid sodium (Sodium Ursodeoxycholate) is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities.</p>Fórmula:C24H40NaO4Pureza:99.66% - 99.96%Cor e Forma:SolidPeso molecular:415.56CAY10789
CAS:<p>CAY10789: potent CysLT1R antagonist (IC50 2.8 µM), GPBAR1 agonist (EC50 3 µM), reduces U937 cell adhesion, TNF-α, stable with promising pharmacokinetics.</p>Fórmula:C17H15NO2Cor e Forma:SolidPeso molecular:265.31WB403
CAS:<p>WB403 activates TGR5, lowers fasting/postprandial glucose and HbA1c, enhances glucose tolerance, and normalizes pancreatic α/β-cells in diabetic mice.</p>Fórmula:C19H19BrN2OSPureza:98%Cor e Forma:SolidPeso molecular:403.34TGR5 agonist 3
CAS:<p>Compound 8, a cholic acid derivative, functions as a selective TGR5 agonist and exhibits an EC50 value of 5 μM [1].</p>Fórmula:C28H48O5Cor e Forma:SolidPeso molecular:464.68INT-777 R-enantiomer
CAS:<p>INT-777 is the R-enantiomer of INT-777, less potent than INT-777,EC50 of 4.79 μM for TGR5.</p>Fórmula:C27H46O5Pureza:98%Cor e Forma:SolidPeso molecular:450.65RO5527239
CAS:<p>RO5527239 is a potent, orally available GPBAR1 agonist agent.</p>Fórmula:C28H31N3O3Pureza:98%Cor e Forma:SolidPeso molecular:457.56INT-777
CAS:<p>INT-777 (S-EMCA) is a potent TGR5 agonist with an EC50 of 0.82 μM.</p>Fórmula:C27H46O5Pureza:99.89%Cor e Forma:SolidPeso molecular:450.655-HT7R antagonist 1
<p>5-HT7R antagonist 1 is a G protein-biased antagonist with Ki of 6.5 nM for 5-HT 7R.</p>Fórmula:C14H18Cl2N4Cor e Forma:SolidPeso molecular:313.23TGR5 Receptor Agonist 3
CAS:<p>TGR5 Receptor Agonist 3 is a GPBAR1 agonist with EC50 of 16.4 nM (hTGR5) & 209 nM (mTGR5), ensures gallbladder safety and reduces filling.</p>Fórmula:C29H27N3O6Cor e Forma:SolidPeso molecular:513.54GPBAR1-IN-3
CAS:<p>GPBAR1-IN-3 (Compound 14) is both a selective agonist for GPBAR1, with an EC50 value of 0.17 μM, and an antagonist for CysLT1R [1].</p>Fórmula:C21H23NO2Cor e Forma:SolidPeso molecular:321.41

